| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.17▼ | 1.18▼ | 1.17▼ | 1.17▼ | 1.25▼ |
| MA10 | 1.19▼ | 1.20▼ | 1.20▼ | 1.20▼ | 1.22▼ |
| MA20 | 1.22▼ | 1.23▼ | 1.23▼ | 1.29▼ | 1.32▼ |
| MA50 | 1.26▼ | 1.32▼ | 1.33▼ | 1.27▼ | 1.36▼ |
| MA100 | 1.34▼ | 1.27▼ | 1.26▼ | 1.35▼ | 1.63▼ |
| MA200 | 1.25▼ | 1.33▼ | 1.34▼ | 1.44▼ | 2.61▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.006▼ | -0.007▼ | -0.019▼ | -0.017▼ |
| RSI | 36.300▼ | 35.960▼ | 36.651▼ | 40.911▼ | 42.658▼ |
| STOCH | 16.503▼ | 16.667▼ | 16.725▼ | 15.681▼ | 27.749 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -90.000▼ | -86.567▼ |
| CCI | -113.090▼ | -118.121▼ | -124.029▼ | -106.385▼ | -82.004 |
| CDL | $MRKR Doji Candlestick Pattern Detected | Set Alert |
|
Tuesday, September 15, 2026 04:00 AM
Merck & Co Inc (NYSE:MRK) recently announced a total dividend of $0.85 per share, with the ex-dividend date set for 2026-09-15. This amount includes a $0.85 per share cash dividend payable on ...
|
|
Monday, September 14, 2026 12:23 AM
Perspective Therapeutics and Merck will evaluate PSV359 with Keytruda in a Phase 1/2a study of FAP-α-positive lung and colorectal cancers.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/09/26 | 1.17 | 1.18 | 1.13 | 1.14 | 35,900 |
| 15/09/26 | 1.17 | 1.23 | 1.15 | 1.17 | 11,899 |
| 14/09/26 | 1.16 | 1.2302 | 1.16 | 1.17 | 17,380 |
| 11/09/26 | 1.20 | 1.245 | 1.10 | 1.15 | 59,368 |
| 10/09/26 | 1.21 | 1.23 | 1.18 | 1.20 | 55,516 |
| 09/09/26 | 1.29 | 1.29 | 1.21 | 1.21 | 71,159 |
| 08/09/26 | 1.19 | 1.39 | 1.19 | 1.28 | 200,296 |
| 04/09/26 | 1.25 | 1.3099 | 1.18 | 1.18 | 35,306 |
| 03/09/26 | 1.24 | 1.3148 | 1.2235 | 1.24 | 43,434 |
| 02/09/26 | 1.25 | 1.3303 | 1.24 | 1.25 | 167,576 |
|
|
||||
|
|
||||
|
|